Health ❯Healthcare ❯Medical Research ❯Neurology

Alzheimer's Disease

Wake Forest Plans Expanded Trials After PET Study Validates Intranasal Insulin Delivery

PET imaging confirmation of targeted insulin delivery enables expanded trials to refine personalized dosing strategies.

Cancer Drugs Reverse Alzheimer’s Pathology in Mice, Advance to Clinical Trials

AI Stratification Uncovers Alzheimer’s Drug Efficacy, Drives NHS Toward Precision Trials

UNM Launches Phase 1a/1b Trial of Tau-Targeting Alzheimer’s Vaccine

Four Distinct Alzheimer’s Progression Pathways Validated in Diverse Cohorts

FDA Approves 95% Sensitive Blood Test for Alzheimer’s

Alzheimer’s Drug Trials Surge 11% in 2025 as NICE Reviews Lecanemab and Donanemab

Study Finds Alzheimer’s Risk Disclosure Reduces Anxiety but Dampens Motivation for Healthy Habits

Living Human Brain Tissue Provides Breakthrough Insights Into Alzheimer’s Disease

Shingles Vaccine Linked to 20% Dementia Risk Reduction in Landmark Study

Blood Test Advances Alzheimer’s Diagnosis and Staging with 92% Accuracy

Breakthrough Blood Test for Alzheimer’s Diagnoses Disease and Tracks Progression

Study Suggests Long-Term Anti-Amyloid Therapy May Delay Early-Onset Alzheimer’s

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

Dopamine Shows Promise in Reducing Alzheimer's Plaques

New Alzheimer's Drugs Face Scrutiny Over Efficacy and Safety

GLP-1 Drug Shows Promise in Slowing Alzheimer's Cognitive Decline

New Blood Tests Enhance Alzheimer's Diagnosis Accuracy